QA: Zynerba Pharmaceuticals Inc in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001621443_2017_Zynerba_Pharmaceuticals_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001621443, Zynerba Pharmaceuticals Inc

  xvar xval
0 AssetsCurrent 36,410,692
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 143,382
3 remainder_Assets 200
4 LiabilitiesCurrent 6,966,966
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 6,430,252
9 ResearchAndDevelopmentExpense 16,784,626
10 remainder_Expenses -27,543
11 remainder_Revenues 7,250
12 remainder_NetIncome -208,422
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 36,554,274
1 Liabilities 6,966,966
2 Expenses 23,187,335
3 Revenues 7,250
4 StockholdersEquity 29,587,308
5 NetIncome -23,388,507
6 ComprehensiveNetIncome -23,388,507
7 BaseVar 33,462,124
8 EconomicCapitalRatiobeforeLimitedLiability 1.89
9 EconomicCapitalRatio 2.95

Edgar->Model Mapping

Feature Distribution

Change over Time